Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial-Reference-Cited by-同舟云学术

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

Published:2015-01 Issue:1 Volume:16 Page:76-86
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Sternberg Cora N,Skoneczna Iwona,Kerst J Martijn,Albers Peter,Fossa Sophie D,Agerbaek Mads,Dumez Herlinde,de Santis Maria,Théodore Christine,Leahy Michael G,Chester John D,Verbaeys Antony,Daugaard Gedske,Wood Lori,Witjes J Alfred,de Wit Ronald,Geoffrois Lionel,Sengelov Lisa,Thalmann George,Charpentier Danielle,Rolland Frédéric,Mignot Laurent,Sundar Santhanam,Symonds Paul,Graham John,Joly Florence,Marreaud Sandrine,Collette Laurence,Sylvester Richard

Funder

Canadian Cancer Society Research Institute

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience;Yafi;BJU Int,2010

2. International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012. ICUD-EAU International Consultation on Bladder Cancer 2012: chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings;Sternberg;Eur Urol,2013

3. Adjuvant therapy in the elderly: making the right decision;Muss;J Clin Oncol,2007

4. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients;Stein;J Clin Oncol,2001

5. The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why;Sylvester;Ann Oncol,2000

Cited by 316 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Survival Benefits of Perioperative Chemotherapy in Frail and Morbid Muscle-Invasive Bladder Cancer Patients;Journal of Personalized Medicine;2024-09-09

2. Perioperative chemotherapy and immunotherapy to optimize cystectomy outcomes in the curative intent of non-metastatic muscle-invasive bladder cancer: A systematic review and meta-analysis;The French Journal of Urology;2024-09

3. Early Adjuvant Chemotherapy Improves Survival in Muscle Invasive Bladder Cancer: A Systematic Review and Meta-analysis;Urology;2024-09

4. Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target;BMC Cancer;2024-08-19

5. Race/Ethnicity Affects Access and Survival Differences After Neoadjuvant or Adjuvant Chemotherapy at Radical Cystectomy in Urothelial Carcinoma Patients;Journal of Racial and Ethnic Health Disparities;2024-08-19